Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D S Guttery

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 17, 2025
Intercepting endocrine resistance in ER-positive/HER2-negative metastatic breast cancer: insights from the PADA-1 trialD S Guttery, J A Shaw, J Stebbing
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 26, 2021
Innovative Follow-up Strategies for Endometrial CancerA Collins, A Taylor, D S Guttery, et al.
NPJ Precision Oncology|March 24, 2026
Design and evaluation of a custom circulating tumour DNA assay to detect endometrial cancer recurrenceM Wadsley, D S Guttery, C Cowley, et al.
British Journal of Cancer|March 24, 2011
Detection of HER2 amplification in circulating free DNA in patients with breast cancerK Page, N Hava, B Ward, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 2021
Prevalence of ctDNA in early screen-detected breast cancers using highly sensitive and specific dual molecular barcoded personalised mutation assaysK Page, L J Martinson, R K Hastings, et al.
British Journal of Cancer|December 15, 2011
The presence of disseminated tumour cells in the bone marrow is inversely related to circulating free DNA in plasma in breast cancer dormancyR E Payne, N L Hava, K Page, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 20, 2021
Longitudinal whole-exome sequencing of cell-free DNA for tracking the co-evolutionary tumor and immune evasion dynamics: longitudinal data from a single patientR K Hastings, M R Openshaw, M Vazquez, et al.
Breast Cancer Research and Treatment|November 15, 2014
NEOCENT: a randomised feasibility and translational study comparing neoadjuvant endocrine therapy with chemotherapy in ER-rich postmenopausal primary breast cancerC Palmieri, S Cleator, L S Kilburn, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 17, 2025
Intercepting endocrine resistance in ER-positive/HER2-negative metastatic breast cancer: insights from the PADA-1 trialD S Guttery, J A Shaw, J Stebbing
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 26, 2021
Innovative Follow-up Strategies for Endometrial CancerA Collins, A Taylor, D S Guttery, et al.
NPJ Precision Oncology|March 24, 2026
Design and evaluation of a custom circulating tumour DNA assay to detect endometrial cancer recurrenceM Wadsley, D S Guttery, C Cowley, et al.
British Journal of Cancer|March 24, 2011
Detection of HER2 amplification in circulating free DNA in patients with breast cancerK Page, N Hava, B Ward, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 2021
Prevalence of ctDNA in early screen-detected breast cancers using highly sensitive and specific dual molecular barcoded personalised mutation assaysK Page, L J Martinson, R K Hastings, et al.
British Journal of Cancer|December 15, 2011
The presence of disseminated tumour cells in the bone marrow is inversely related to circulating free DNA in plasma in breast cancer dormancyR E Payne, N L Hava, K Page, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 20, 2021
Longitudinal whole-exome sequencing of cell-free DNA for tracking the co-evolutionary tumor and immune evasion dynamics: longitudinal data from a single patientR K Hastings, M R Openshaw, M Vazquez, et al.
Breast Cancer Research and Treatment|November 15, 2014
NEOCENT: a randomised feasibility and translational study comparing neoadjuvant endocrine therapy with chemotherapy in ER-rich postmenopausal primary breast cancerC Palmieri, S Cleator, L S Kilburn, et al.
Pageof 1